Fertile grounds in Asia for private equity investments in healthcare
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
THERE has never been a better time to raise money for Asian companies in the life sciences sector as the Covid-19 pandemic exposes cracks in the healthcare systems and distribution channels, forcing many in healthcare and insurance to seek innovative solutions.
Industry professionals including AXA chief digital and transformation officer Tomasz Kurczyk; Novartis Philippines country corporate affairs head Christine Fajardo; and healthcare industry expert Rahul Bibhuti recently spoke at a webinar by Isentia that the healthcare landscape is undergoing rapid changes and seeing plenty of new opportunities.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?
